Replies to post #138588 on Biotech Values

[DewDiligence]

The cumulative vote on the two questions was 41-1 in favor of the NGF drugs. Can't recall such a one-sided panel in which votes on multiple questions were taken.

[jq1234]

Anti-NGF mAb: PFE disclosed today FDA lifted a partial clinical hold earlier this month on the anti-nerve growth factor (NGF) humanized mAb tanezumab. PFE will resume ph3 trial for chronic pain in 2014.